NEW DELHI : Treating severe covid-19 patients with the anticancer drug bevacizumab may reduce mortality and speed up recovery, a clinical study done in Italy and China has showed.
Bevacizumab is a medication that has been used to treat various types of cancer since 2004. Led by researchers at Karolinska Institutet in Sweden between February and April 2020 the study findings showed that on average, blood oxygen levels, body temperature and inflammatory markers significantly improved in patients treated with a single dose of bevacizumab in addition to standard care.The research is published in Nature Communications. "To reduce covid-19 mortality, we aim to develop an effective therapeutic paradigm for treating patients with severe covid-19,".